社区获得性肺炎3种治疗方案的成本效果分析

The cost-effectiveness analysis of three therapeutic schemes for sociapheumonia infections

目的 评价氨苄西林 舒巴坦针组 (A组 )、头孢哌酮针组 (B组 )、左氧氟沙星针组 (C组 ) 3种方案治疗社区获得性肺炎的药物经济学成本与效果。方法 采用回顾性研究方法 ,运用成本 效果分析法对 3种治疗方案进行成本与效果分析。结果 3种治疗方案中 ,A组、B组、C组总成本分别为 1770 96元、1896 0 0元、115 3 86元 ,治愈率分别为 4 6 2 %、6 1 5 %、6 9 2 % ,每增加 1个单位效果 ,A组与B组较C组需多花成本分别为 2 8 4 9元和 5 2 4 5元。结论 C组为治疗社区获得性肺炎的较佳治疗方案 ,通过成本 效果分析能优化治疗方案、指导合理用药 。

AIM To evaluate the cost effectiveness of three therapeutic schemes, Ampicillin Sulbactam injection(A), Cefoperazone injection(B) and Levofloxacin injection(C) in treating the sociapheumonia infections. METHODS Compared the cost and effectiveness of three therapeutic schemes, by using pharmacoeconomic cost efrfectiveness analysis of retrospective study. RESULTS The total costs of A,B and C schemes were RMB 1 770 96 , 1 896 00 and 1 153 86 yuans, respectively. And the effective ratios were 46 2%, 61 5% and 69 2%, respectively. An increase of 1% effective rate in group C saved RMB 28 49 and 52 45 yuans in comparison with that in group A and B. CONCLUSION According to the evalution with pharmacoeconomic cost effectiveness analysis, the group C is the best one for treating sociapheumonia infection. The cost effective analysis play an important role in optimizing therpeutic scheme, guiding rational use of drug and rising effective.